Projekti

Kick-off meeting of the new European project EUROHELICAN

Projekti

Ljubljana, November 18 2022 – The National Institute of Public Health (NIJZ) organized the “Kick-off” meeting of the new European project EUROHELICAN – Accelerating gastric cancer reduction in Europe through Helicobacter pylori eradication. The general objective of the EUROHELICAN project is to assess the feasibility of population-based Helicobacter pylori test- and treat strategy for gastric cancer prevention in Europe. In the EUROHELICAN project, co-financed by the European Union, beside the NIJZ, participate the Community Healthcare Center dr. Adolf Drolc Maribor, the International Agency for Research on Cancer (IARC) of the World Health Organization, University of Latvia Institute of Clinical and Preventive Medicine and Nantes University Hospital. The project will last from 1 November 2022 to 30 April 2025.

Zadnje posodobljeno: 23.11.2022
Objavljeno: 23.11.2022

 

Gastric cancer, with more than 1 million new cases and almost 800,000 deaths worldwide in 2020, is the fifth most frequently diagnosed cancer type and the fourth most common cause of cancer death worldwide. In Europe, gastric cancer is still an important public health issue, with the regions of Central and Eastern Europe having the highest gastric cancer incidence worldwide, second to Eastern Asia. In Europe, gastric cancer has a poor prognosis with 5-year relative survival rate between 19-30 %. Despite the recent therapeutic progress, the 5-year overall survival has not been significantly improved for the last decades in most of the European countries.

Infection with the Helicobacter pylori (H. pylori) means a high risk of developing stomach cancer. Given its absolute burden and the significant prevalence of treatable H. pylori infection worldwide, the best way to reduce gastric cancer mortality is through preventive action. Therefore, pilot population testing and treatment of H. pylori is proposed as a strategy for the prevention of stomach cancer within the framework of the EUROHELICAN project, which would significantly prevent the loss of lives or the quality of life due to this malignant disease.

By treating the infection, we would prevent and eliminate other gastroenterological problems: stomach and duodenal ulcer, gastritis (inflammation of the stomach lining), dyspepsia (feeling of fullness, bloating, burning pain, fainting, nausea), iron deficiency anemia, MALT lymphoma, vitamin deficiency B12, autoimmune disease idiopathic thrombocytopenic purpura.

The results from this project will aide policy makers incorporate the population-based H. pylori test- and treat strategy into their healthcare priorities for gastric cancer prevention while balancing its effectiveness, feasibility and acceptability with long-term potential adverse effects.

At the kickoff meeting, all project partners spoke constructively about the project’s main goals, work packages, individual activities, and precisely determined the cooperation procedures for the successful implementation of the project.


Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Za dobro javno zdravje
Koronavirus

Spremljanje okužb s SARS-CoV-2 (covid-19)

Podrobno
Preprečevanje poškodb

Nasveti za varno in veselo noč čarovnic

Podrobno
Nalezljive bolezni

Tedensko spremljanje respiratornega sincicijskega virusa (RSV)

Podrobno